Ever wonder what’s really going on behind the scenes in the prescription drug and pharmaceutical industry? We sure do. And that’s why we’ve got freshman Representative Diana Harshbarger on the show today. She may be new to the 117th Congress but she’s been a pharmacist for over 30 years. Rep. Harshbarger has penned H.R.129 (supported by AMAC), a bill directed at the role Pharmacy Benefit Managers play in drug pricing and the enormous power they have to affect your wallet. Rebates, kickbacks, and zero government accountability are the usual suspects in this medicinal mystery.
Your AMAC News App is the place to go for truthful, breaking news where you are and whenever you want!
We hope you've enjoyed this article. While you're here, we have a small favor to ask...
Support the AMAC Foundation. Our 501(c)(3) powers the AMAC Foundation’s Social Security Advisory Services. This team of nationally accredited advisors offers on-time, on-the-mark guidance for those approaching or receiving Social Security – at no cost.Donate Now